SETD2 is also a tumor suppressor, with SETD2 mutations being found in a wide range of cancers, including in acute leukemia where KMT2A-rearranged leukemias more frequently harbor SETD2 mutations than non-KMT2A-rearranged leukemias61–63. Here, SETD2 is linked to cancer.